Protective effect of polymyxin B sulfate in experimental enterobacterial infection in mice

Area of Science:

• Pharmacology and Toxicology
• Infectious Diseases
• Microbiology

Background:

• Sepsis remains a critical global health challenge, often caused by Gram-negative bacteria.
• Endotoxins from these bacteria are key mediators of sepsis-induced inflammation and organ damage.
• Polymyxin B sulfate is an antibiotic known for its activity against Gram-negative bacteria.

Purpose of the Study:

• To investigate the anti-endotoxic efficacy of polymyxin B sulfate.
• To evaluate the protective effects of polymyxin B sulfate in a mouse model of enterobacterial sepsis.

Main Methods:

• A mouse model of intraperitoneal enterobacterial sepsis was established.
• Mice were challenged with a lethal dose of Serratia marcescens.
• Therapeutic doses of polymyxin B sulfate were administered at various time points (before or after challenge).

Main Results:

• Polymyxin B sulfate administration resulted in statistically significant protective effects.
• Clinically significant improvements in survival and/or disease severity were observed.
• Protection was evident regardless of whether polymyxin B sulfate was given pre- or post-challenge.

Conclusions:

• Polymyxin B sulfate exhibits potent anti-endotoxic properties.
• The antibiotic confers significant protection against lethal enterobacterial sepsis.
• Timely administration of polymyxin B sulfate can be a viable therapeutic strategy in sepsis.